You are here

Article info

Article menu
Download PDFPDF
PostScript
Correspondence
Immunohistochemistry of p16 in nevi of pregnancy and nevoid melanomas: a clinical follow-up study

Authors

  • Stephen S Koh Kaiser Foundation Hospitals, Pasadena, California, USA Department of Pathology and Dermatopathology, Kaiser Permanente Anaheim/Irvine Medical Center, Anaheim, California, USA PubMed articlesGoogle scholar articles
  • Sean K Lau Kaiser Foundation Hospitals, Pasadena, California, USA Department of Pathology and Dermatopathology, Kaiser Permanente Anaheim/Irvine Medical Center, Anaheim, California, USA PubMed articlesGoogle scholar articles
  • Brian F Roehmholdt Kaiser Foundation Hospitals, Pasadena, California, USA Department of Pathology and Dermatopathology, Kaiser Permanente Fontana/Ontario Medical Center, Fontana, California, USA PubMed articlesGoogle scholar articles
  • David S Cassarino Kaiser Foundation Hospitals, Pasadena, California, USA Department of Pathology and Dermatopathology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Stephen S Koh, Department of Pathology and Dermatopathology, Kaiser Permanente Orange County - Anaheim/Irvine Medical Center, Anaheim, CA 92806, USA; stephen.s.koh{at}kp.org
View Full Text

Citation

Koh SS, Lau SK, Roehmholdt BF, et al
Immunohistochemistry of p16 in nevi of pregnancy and nevoid melanomas: a clinical follow-up study
Journal of Clinical Pathology 2022;75:68-70.

Publication history

  • Received November 24, 2020
  • Revised January 13, 2021
  • Accepted February 1, 2021
  • First published March 22, 2021.
Online issue publication 
January 08, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.